Navigation Links
ADHD Treatment -Phase 3 data on Lisdexamfetamine dimesylate Presented

The investigational ADHD treatment, lisdexamfetamine dimesylate (also known as NRP104 or LDX) by Shire plc and its collaborative partner// New River Pharmacuticals has yielded a good response in children with Attention Deficit Hyperactivity Disorder, it was announced today.

The data was presented at a national meeting of child and adolescent psychiatrists last weekend.

The study was done on 269 children between 6 and 12 who were treated for six months in an open label phase III study. A 60% improvement has been recorded in the primary ratings scale scores for ADHD symptoms, so the potential for LDX to be used effectively in ADHD has been recognised.

New River Pharmaceuticals formulated LDX as a new medication for ADHD which will act all day till 6 p.m.

Source-Eurekalert
MAL
'"/>




Page: 1

Related medicine news :

1. Advances in Treatment of Cataracts
2. Recommendations for Treatment of Blood Pressue
3. Treatment for Menieres disease
4. Treatment for pre-menstrual syndrome is ineffective
5. Better Treatment for obesity
6. Gene Treatment for Heart Disease
7. More People Seeking Treatment for Depression
8. Focused Treatment For Childhood Cancer
9. Inadequate Drug Treatment For Youth
10. FDA Approves New surgery Treatment for Farsightedness
11. Treatment of antibiotics ineffectual in bronchitis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... ... countries clearly shows that over the last decade, student well-being has seriously declined. ... the boxes of formal education, join the Islamic State to turn the historic ...
(Date:4/24/2017)... ... 24, 2017 , ... “Learning to Use Your SPIRITUAL COMPASS To Navigate Life ... Your SPIRITUAL COMPASS To Navigate Life Issues” is the creation of published author, Rachel ... Board of Directors for CONTACT USA, and former member of the American Association of ...
(Date:4/24/2017)... Miami, FL (PRWEB) , ... April 24, 2017 ... ... John Paul Gallardo, DDS, PA will be attending the 2017 Oral Reconstruction Foundation’s ... 4-6, 2017. , The Oral Reconstruction Foundation will present its annual Global Symposium ...
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... ... lifestyle brands, work wear distributors and International relief organizations across the globe to ... company also offers lifestyle and work wear collections via insectshield.com . In ...
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... ... and laboratory-grade deionized water from the same place. From 101 Water Texas, here ... Satisfaction: Patients and staff can enjoy a continuous supply of pure, fresh, oxygenated ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 2017 Cardiology devices segment is anticipated to reach ... The Cardiology Devices segment is likely to create absolute $ ... 2018 over 2017. By the end of 2027, Cardiology Devices ... US$ 700 Mn, expanding at a CAGR of 18.4% over ... Asia Pacific reprocessed medical devices market in ...
(Date:4/19/2017)... VIEW, Calif. , April 19, 2017  IRIDEX ... it will release financial results for the first quarter ... 3, 2017.  The Company,s management team will host a ... 5:30 p.m. ET. Investors interested in listening ... (844) 707-0665 for domestic callers or (703) 326-3030 for ...
(Date:4/19/2017)... 2017 Global Prostate Cancer Therapeutics Market: ... prostate cancer therapeutics market analyzes the current and ... of prostate cancer, launch of promising emerging therapies, ... new drugs & therapeutic biological products, and high ... lesser side effects are some of the drivers ...
Breaking Medicine Technology: